The meeting between SpectraCure and Memorial Sloan Kettering Cancer Center in New York, USA takes place tomorrow, March 13 2020
Refers to the latest travel information regarding the United States. The scheduled meeting, "Site Initiation Visit", between SpectraCure and Memorial Sloan Kettering Cancer Center in New York, USA, will be conducted tomorrow Friday. It is a formal meeting for the start-up and review of procedures and equipment. After the meeting is completed, the study is underway and recruitment of patients can begin. For further information please contact:Johannes Swartling, CTO SpectraCure. Telefon: +46 (0) 40-16 20 70, e-post: jsw@spectracure.comMasoud Khayyami, CEO SpectraCure. E-post: mk@